![]() One way of looking at tamponade is that the effusion competes with the cardiac chambers to occupy the limited volume within and surrounded by the pericardium. Normal pericardial pressure is zero any increase can have hemodynamic consequences. The primary hemodynamic pathophysiologic process in the development of tamponade is increased pericardial pressure that impairs diastolic filling. Once a critical threshold of pericardial fluid is reached, the pericardial pressure rises in a nonlinear fashion, resulting in hemodynamic compromise or cardiac tamponade ( Figure 19.1).įigure 19.1 Schematic of the phases of cardiac tamponade. Fluid that accumulates in the pericardial space can be serous, sero‐sanguineous, hemorrhagic, chylous, or a combination of the above. A myriad of conditions produce pathologic accumulation of fluid in the pericardial cavity. The normal pericardial space contains 15–40 mL of pericardial fluid. The pericardium stabilizes the heart within the thoracic cavity by virtue of its ligamentous attachments, and also prevents extreme dilatation in the setting of a sudden rise of intracardiac volume. It normally contains a thin film of serous fluid that enables the heart to move and beat in a frictionless environment. The potential space between the parietal and visceral layers of the serous pericardium is called the pericardial cavity. The visceral pericardium is reflected onto the heart, where it forms the epicardium, the external layer of the heart wall. The parietal pericardium is fused to the internal surface of the fibrous pericardium. Note lack of significant correlation between PCWP and LVEDP in COPD patients, and poor correlation in obese patients.The pericardium is a fibroserous sac consisting of two parts: (a) a strong external layer composed of tough fibrous tissue, called the fibrous pericardium and (b) an internal double‐layered sac (visceral and parietal pericardium) composed of a transparent membrane called the serous pericardium. Sensitivity = sensitivity for the outcome of LVEDP >15 mmHg Specificity = specificity for the outcome of LVEDP >15 mmHg.Ĭorrelations between PCWP and LEDP in patients with or without diabetes (A, B), hypertension (C, D), COPD (E, F) or CHF (G, H), as well as for patients < or ≥65 years of age (I, J), and for patients with a body mass index (BMI) <25 or ≥30 (K, L). (C) If a cut point of LVEDP ≤20 mmHg was used, the AUROC would be 0.75 (95% CI, 0.63 to 0.88). (B) If a cut point of LVEDP ≤10 mmHg was used, the AUROC would be 0.89 (95% CI, 0.79 to 0.99). (A) AUROC = 0.81 (95% CI, 0.69 to 0.94) using a cut point of LVEDP ≤15 mmHg to indicate pre-capillary PH. 3 for explanation of Bland-Altman plot labeling.ĭistribution of patients with LVEDP ≤15 mmHg or LVEDP >15 mmHg in patients with PCWP ≤15 mmHg and PVR >3 WU (upper panel black), TPG >12 mmHg (middle panel dark grey), or DPG >7 mmHg (bottom panel light grey).ĭPG, diastolic pressure gradient PVR, pulmonary vascular resistance TPG, transpulmonary gradient.Īrea under the receiver operating characteristic curve (AUROC) of PCWP against LVEDP in the entire study population. Shaded area in (A) represents the patients with PCWP ≤15 mmHg, but LVEDP >15 mmHg, thus indicating patients that would have been incorrectly classified as pre-capillary PH in absence of LVEDP measurement. 15 mmHg horizontal line divides patients in patients with LVEDP ≤15 mmHg or >15 mmHg.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |